ABSTRACT
The membrane (M) glycoprotein of coronaviruses (CoVs) serves as the nidus for virion assembly. Using a yeast two‐hybrid screen, we identified the interaction of the cytosolic tail of Murine Hepatitis Virus (MHV‐CoV) M protein with Myosin Vb (MYO5B) (Figure 1A). MHV‐CoV M interacts specifically with the alternative splice variant of cellular MYO5B including Exon D (MYO5B+D), that also mediates interaction with cellular Rab10. When co‐expressed in human lung epithelial A549 and canine kidney epithelial MDCK cells, MYO5B+D co‐localized with MHV‐CoV M protein, as well as with M proteins from porcine epidemic diarrhea Virus (PEDV‐CoV), Middle East Respiratory Syndrome (MERS‐CoV) and Severe Acute Respiratory Syndrome 2 (SARS‐CoV‐2) (Figure 2). M‐GFP chimeric proteins co‐expressed with mCherry‐MYO5B+D also co‐localized with endogenous Rab10 and Rab11a (Figure 1B,C). We identified point mutations in MHV‐CoV M that blocked the interaction with MYO5B+D in yeast 2‐hybrid assays (Figure 1B). One of these point mutations (E121K) was previously shown to block MHV‐CoV virion assembly, and it blocked interaction with MYO5B+D. The E to K mutation at homologous positions in PEDV‐CoV, MERS‐CoV and SARS‐CoV‐2 M proteins also blocked colocalization with MYO5B+D. Knockdown of Rab10 blocked the co‐localization of the M proteins with MYO5B+D (Figure 2). Re‐expression of Cerulein‐Rab10 in Rab10 KD cells re‐established colocalization between M proteins and MYO5B+D (Figure 2). Our results suggest that the interaction of CoV M proteins with MYO5B+D may play a role in regulating their trafficking through Rab10‐containing membrane systems in epithelial cells.
ABSTRACT
The Omicron SARS-CoV-2 variant has been designated as a variant of concern because its spike protein is heavily mutated. In particular, the Omicron spike is mutated at five positions (K417, N440, E484, Q493, and N501) that have been associated with escape from neutralizing antibodies induced by either infection with or immunization against the early Washington strain of SARS-CoV-2. The mouse-adapted strain of SARS-CoV-2, SARS2-N501YMA30, contains a spike that is also heavily mutated, with mutations at four of the five positions in the Omicron spike associated with neutralizing antibody escape (K417, E484, Q493, and N501). In this manuscript, we show that intranasal immunization with a pre-fusion stabilized Washington strain spike, expressed from a highly attenuated, replication-competent vaccinia virus construct, NYVAC-KC, fully protected mice against symptoms and death from SARS2-N501YMA30. Similarly, immunization by scarification on the skin fully protected against death, but not from mild disease. This data demonstrates that the Washington strain spike, when expressed from a highly attenuated, replication-competent poxvirus-administered without parenteral injection-can fully protect against the heavily mutated mouse-adapted SARS2-N501YMA30.
ABSTRACT
An improved analysis for single-particle imaging (SPI) experiments, using the limited data, is presented here. Results are based on a study of bacteriophage PR772 performed at the Atomic, Molecular and Optical Science instrument at the Linac Coherent Light Source as part of the SPI initiative. Existing methods were modified to cope with the shortcomings of the experimental data: inaccessibility of information from half of the detector and a small fraction of single hits. The general SPI analysis workflow was upgraded with the expectation-maximization based classification of diffraction patterns and mode decomposition on the final virus-structure determination step. The presented processing pipeline allowed us to determine the 3D structure of bacteriophage PR772 without symmetry constraints with a spatial resolution of 6.9â nm. The obtained resolution was limited by the scattering intensity during the experiment and the relatively small number of single hits.